Hypothalamic Hamartoma with Precocious Puberty and Gelastic Seizures in a Boy: Case Report

    October 2013 in “ International Journal of Pediatric Endocrinology/International journal of pediatric endocrinology ”
    Iman Hendarman, Aditiawati, Msy Rita Dewi Arifin
    TLDR A boy with early puberty and laughing seizures was treated, stopping seizures and slowing puberty.
    This case report described a 5-year and 7-month-old boy with hypothalamic hamartoma presenting with pubertas precox and gelastic seizures. The boy exhibited premature pubic hair growth, frequent uncontrolled laughing, and accelerated height growth. Laboratory tests showed elevated levels of FSH, LH, testosterone, and 17α-hydroxyprogesterone. Imaging revealed a lesion in the suprasellar region. He was treated with leuprorelin and valproic acid. After 3 years, his pubertal status remained stable, and his bone age was appropriate for a 13-year-old, with no gelastic seizures reported. The report noted that while leuprorelin's effectiveness for pubertas precox in hypothalamic hamartoma is controversial, valproic acid was effective for managing gelastic seizures.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 27 results

      community EMA is re-examining Winlevi (clascoterone at lower concentration)

      in Treatment  7 upvotes 7 months ago
      Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

      community Mechanism of action of alfatradiol (17 alpha estradiol)

      in Research/Science  6 upvotes 1 year ago
      The conversation discusses the mechanism of action of alfatradiol (17 alpha estradiol) in treating hair loss. It explores theories that it either inhibits 5 alpha reductase to prevent T->DHT conversion or aromatizes scalp T into 17-alpha-estradiol to save hair.

      community CB-03-01 / Breezula Personal Results

      in Treatment  13 upvotes 1 week ago
      The user shared their experience with CB-03-01 (Breezula/Clascoterone) for hair loss, noting reduced shedding and improved hair appearance but experiencing significant sleep disturbances and low energy due to HPA axis suppression. They decided to stop using it due to these side effects and are waiting for GT20029 as an alternative.

      community Injecting estrogen for hairline regrow

      in Chat  268 upvotes 9 months ago
      A user plans to undergo a temporary MtF transformation to regrow hair, using estrogen, RU58841, and Dutasteride, then revert with testosterone. Many users criticize the plan, suggesting alternatives like hair transplants, and emphasize that estrogen is not a reliable solution for hair regrowth.

    Similar Research

    5 / 1000+ results
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      30 citations , July 2004 in “Fertility and Sterility”
      Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      21 citations , September 2004 in “Fertility and Sterility”
      Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      78 citations , November 2008 in “Fertility and Sterility”
      Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      38 citations , October 2006 in “Fertility and Sterility”
      The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.